EP3429591
Setnar þíenó[2,3-d]pýrimídín-afleiður sem hindrar fyrir menín-MLL og aðferðir til notkunar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.3.2017EP published:
15.3.2023EP application number:
17767462.9
EP translation filed:
12.6.2023Grant published:
15.7.2023EPO information:
European Patent Register
Max expiry date:
14.3.2037Expiry date:
14.3.2027Next due date:
31.3.2027
Title in English:
SUBSTITUTED THIENO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF MENIN-MLL AND METHODS OF USELanguage of the patent:
English
Timeline
Today
15.3.2017EP application
15.3.2023EP Publication
12.6.2023Translation submitted
15.7.2023Registration published
14.3.2027Expires
Owner
Name:
Kura Oncology, Inc.Address:
12730 High Bluff Drive, Suite 400, San Diego, CA 92130, US
Name:
The Regents of The University of MichiganAddress:
1600 Huron Parkway 2nd Floor, Ann Arbor, Michigan 48109, US
Inventor
Name:
WU, TaoAddress:
Carlsbad, CA 92009, US
Name:
LI, LianshengAddress:
San Diego, CA 92130, US
Name:
WANG, YiAddress:
San Diego, CA 92122, US
Name:
REN, PingdaAddress:
San Diego, CA 92130, US
Name:
GREMBECKA, JolantaAddress:
Ann Arbor, MI 48109, US
Name:
CIERPICKI, TomaszAddress:
Ann Arbor, MI 48109, US
Name:
KLOSSOWSKI, SzymonAddress:
Ann Arbor, MI 48109, US
Name:
POLLOCK, JonathanAddress:
Ann Arbor, MI 48109, US
Name:
BORKIN, DmitryAddress:
Ann Arbor, MI 48109, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662309372 PDate:
16.3.2016Country:
US
Number:
201662334369 PDate:
10.5.2016Country:
US
Number:
201662431389 PDate:
7.12.2016Country:
US
Number:
201762446640 PDate:
16.1.2017Country:
US
Classification
Categories:
A61K 31/535, C07D 495/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.4.2023
Expires: 14.3.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.2.2024
Expires: 14.3.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.2.2025
Expires: 14.3.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.3.2026
Expires: 14.3.2027
Payer: Árnason Faktor ehf.